Leerink Partners analyst Daina Graybosch has maintained their bullish stance on ITOS stock, giving a Buy rating on November 12. Daina ...

Pro forma cash and investment balance of $683.9 million as of September 30, 2024 expected to provide runway through 2027 across a number of impactful portfolio milestones. WATER ...

Corvus Pharmaceuticals Inc. (CRVS) announced new data highlighting the potential of ciforadenant, the Company's adenosine A2A ...

The probability of event-free survival in patients receiving valsartan 160 mg b.i.d. vs. placebo in addition to optimal medical therapy in patients with systolic heart failure (Kaplan-Meier ...

Try a better option: Opera OneOver 300 million people use Opera One daily, a fully-fledged navigation experience coming with built-in packages, enhanced resource consumption, and great design.Here's ...

By contrast, the Phase 3 future of etru is still undetermined. It is a dual A2a/A2b adenosine receptor antagonist that targets the second node in ATP-adenosine pathway. Adenosine hinders tumor ...

The angiotensin II receptor blockers (ARBs), are highly selective for the AT 1 subtype and will block the effects of angiotensin II on peripheral vessels. Several short-and long-term studies have ...

The pediatrician behind a groundbreaking study showing that puberty blockers did not lead to mental health improvements among young people, claimed her team has not yet published the findings to ...

JK Rowling criticized the delay in publishing a US study on puberty blockers for transgender youth, emphasizing concerns that withholding information due to political pressures harms children.

The government on Tuesday announced a new spam-tracking system to identify and block incoming international calls posing as Indian phone numbers. The system was made operational and within 24 hours of ...